CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma

Published 2023 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Recent Patents on Anti-Cancer Drug Discovery
Volume 19, Issue -, Pages -
Publisher
Bentham Science Publishers Ltd.
Online
2023-10-02
DOI
10.2174/0115748928262221230925090120

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.